74.77
price down icon4.37%   -3.42
after-market Handel nachbörslich: 73.56 -1.21 -1.62%
loading
Schlusskurs vom Vortag:
$78.19
Offen:
$78.82
24-Stunden-Volumen:
4.99M
Relative Volume:
0.94
Marktkapitalisierung:
$28.85B
Einnahmen:
$4.82B
Nettoeinkommen (Verlust:
$930.40M
KGV:
31.98
EPS:
2.3381
Netto-Cashflow:
$1.43B
1W Leistung:
+2.75%
1M Leistung:
+23.36%
6M Leistung:
+10.67%
1J Leistung:
-11.85%
1-Tages-Spanne:
Value
$74.64
$78.91
1-Wochen-Bereich:
Value
$71.53
$78.91
52-Wochen-Spanne:
Value
$54.11
$89.98

Dexcom Inc Stock (DXCM) Company Profile

Name
Firmenname
Dexcom Inc
Name
Telefon
(858) 200-0200
Name
Adresse
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Name
Mitarbeiter
11,100
Name
Twitter
@dexcom
Name
Nächster Verdiensttermin
2026-07-29
Name
Neueste SEC-Einreichungen
Name
DXCM's Discussions on Twitter

Compare DXCM vs ABT, SYK, MDT, BSX, EW

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
DXCM icon
DXCM
Dexcom Inc
74.77 30.17B 4.82B 930.40M 1.43B 2.3381
ABT icon
ABT
Abbott Laboratories
89.17 158.94B 45.13B 6.28B 7.38B 3.5895
SYK icon
SYK
Stryker Corp
308.84 120.38B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
80.25 105.25B 36.36B 4.84B 5.43B 3.7212
BSX icon
BSX
Boston Scientific Corp
48.34 72.77B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
85.98 50.41B 6.30B 1.07B 1.09B 1.8406

Dexcom Inc Stock (DXCM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-03-24 Hochstufung Evercore ISI In-line → Outperform
2026-01-12 Herabstufung Barclays Equal Weight → Underweight
2025-12-02 Hochstufung Morgan Stanley Equal-Weight → Overweight
2025-11-25 Eingeleitet Evercore ISI In-line
2025-10-21 Fortgesetzt Stifel Buy
2025-09-08 Herabstufung Oppenheimer Outperform → Perform
2025-08-21 Eingeleitet Argus Buy
2025-06-16 Eingeleitet Truist Buy
2025-05-30 Eingeleitet Goldman Buy
2025-04-10 Eingeleitet Mizuho Outperform
2025-02-03 Hochstufung Redburn Atlantic Neutral → Buy
2025-01-16 Hochstufung Robert W. Baird Neutral → Outperform
2024-07-26 Herabstufung JP Morgan Overweight → Neutral
2024-07-26 Herabstufung Robert W. Baird Outperform → Neutral
2024-05-30 Eingeleitet Redburn Atlantic Neutral
2024-03-12 Eingeleitet RBC Capital Mkts Outperform
2023-05-30 Fortgesetzt Morgan Stanley Equal-Weight
2023-04-17 Hochstufung Raymond James Outperform → Strong Buy
2023-03-29 Eingeleitet UBS Buy
2023-01-26 Eingeleitet Wolfe Research Outperform
2022-10-18 Eingeleitet Barclays Equal Weight
2022-10-12 Eingeleitet Jefferies Buy
2022-07-15 Eingeleitet Bernstein Outperform
2022-03-02 Fortgesetzt BofA Securities Buy
2022-02-03 Hochstufung BTIG Research Neutral → Buy
2022-01-19 Hochstufung Wells Fargo Equal Weight → Overweight
2022-01-07 Hochstufung Guggenheim Neutral → Buy
2021-10-18 Herabstufung Guggenheim Buy → Neutral
2021-07-21 Fortgesetzt Cowen Outperform
2021-05-28 Hochstufung Wells Fargo Underweight → Equal Weight
2021-05-25 Eingeleitet Barclays Overweight
2021-04-15 Eingeleitet Atlantic Equities Overweight
2021-01-06 Hochstufung UBS Neutral → Buy
2020-10-02 Herabstufung Wells Fargo Equal Weight → Underweight
2020-05-27 Bestätigt Piper Sandler Overweight
2020-05-14 Eingeleitet Wells Fargo Equal Weight
2020-03-05 Eingeleitet Citigroup Buy
2019-11-07 Bestätigt Canaccord Genuity Buy
2019-11-07 Hochstufung Guggenheim Neutral → Buy
2019-10-23 Eingeleitet Stifel Buy
2018-11-28 Eingeleitet UBS Neutral
2018-10-19 Hochstufung Goldman Sell → Neutral
2018-09-12 Hochstufung Northland Capital Under Perform → Market Perform
2018-08-02 Bestätigt Canaccord Genuity Buy
2018-07-02 Hochstufung Raymond James Mkt Perform → Outperform
2018-06-08 Hochstufung JP Morgan Neutral → Overweight
2018-05-11 Eingeleitet BofA/Merrill Buy
2018-05-03 Bestätigt Canaccord Genuity Buy
2018-04-04 Eingeleitet Goldman Sell
2018-04-04 Eingeleitet Guggenheim Neutral
2018-03-23 Hochstufung Robert W. Baird Neutral → Outperform
2018-01-04 Herabstufung Northland Capital Market Perform → Under Perform
2017-09-28 Bestätigt Wedbush Outperform
Alle ansehen

Dexcom Inc Aktie (DXCM) Neueste Nachrichten

pulisher
09:27 AM

TD Cowen raises DexCom stock price target to $95 on data - Investing.com

09:27 AM
pulisher
08:23 AM

TD Cowen Adjusts Price Target on DexCom to $95 From $75, Maintains Buy Rating - marketscreener.com

08:23 AM
pulisher
Jun 09, 2026

DexCom Inc (DXCM)'s Winning Formula: Financial Metrics and Compe - GuruFocus

Jun 09, 2026
pulisher
Jun 09, 2026

Is DexCom stock underperforming the Dow? - MSN

Jun 09, 2026
pulisher
Jun 09, 2026

Dexcom stock (US2521311074): Mizuho lifts target after diabetes study - AD HOC NEWS

Jun 09, 2026
pulisher
Jun 09, 2026

Pumps, patches and fixes at the ADA - BioWorld News

Jun 09, 2026
pulisher
Jun 09, 2026

DXCM to launch Dexcom Flex CGM system for type 2 diabetes in Germany - MSN

Jun 09, 2026
pulisher
Jun 09, 2026

Dexcom bolsters evidence for glucose sensors for Type 2 diabetes - MedTech Dive

Jun 09, 2026
pulisher
Jun 09, 2026

Devon Energy Corp stock (US2521311074): Dividend, oil price moves and what matters for investors - AD HOC NEWS

Jun 09, 2026
pulisher
Jun 09, 2026

Mizuho raises Dexcom stock price target to $85 on diabetes study - Investing.com

Jun 09, 2026
pulisher
Jun 09, 2026

Raymond James Adjusts Price Target on DexCom to $91 From $81, Maintains Strong Buy Rating - marketscreener.com

Jun 09, 2026
pulisher
Jun 08, 2026

DexCom Inc. stock outperforms competitors on strong trading day - MSN

Jun 08, 2026
pulisher
Jun 08, 2026

DexCom Inc (DXCM) Stock Up 5.2% and Still Undervalued -- GF Scor - GuruFocus

Jun 08, 2026
pulisher
Jun 08, 2026

Dexcom reports positive CONNECT data for non-insulin diabetes - MSN

Jun 08, 2026
pulisher
Jun 08, 2026

Clinical Wins Boost Dexcom Growth Story In Type 2 DiabetesDexCom (NASDAQ:DXCM) - Benzinga

Jun 08, 2026
pulisher
Jun 08, 2026

DexCom, Inc. (DXCM) latest stock news and headlines - Yahoo Finance Singapore

Jun 08, 2026
pulisher
Jun 08, 2026

DexCom Reports Positive CONNECT Data for Non-Insulin Diabetes - Yahoo Finance Singapore

Jun 08, 2026
pulisher
Jun 08, 2026

DexCom jumps as new ADA trial data boosts optimism for broader CGM adoption - Quiver Quantitative

Jun 08, 2026
pulisher
Jun 08, 2026

Why is DexCom stock surging today? By Investing.com - Investing.com Canada

Jun 08, 2026
pulisher
Jun 08, 2026

Mizuho Securities Adjusts DexCom Price Target to $85 From $75, Maintains Outperform Rating - marketscreener.com

Jun 08, 2026
pulisher
Jun 08, 2026

Here's why you should retain DexCom stock in your portfolio - MSN

Jun 08, 2026
pulisher
Jun 08, 2026

DexCom, Inc. (DXCM): Investor Outlook Reveals 13.92% Potential Upside In Continuous Glucose Monitoring Market - DirectorsTalk Interviews

Jun 08, 2026
pulisher
Jun 07, 2026

DexCom (DXCM) Reports Positive Trial Results for Glucose Control in Type 2 Diabetes - GuruFocus

Jun 07, 2026
pulisher
Jun 07, 2026

Is It Time To Reassess DexCom (DXCM) After Recent Glucose Monitoring Headlines? - Sahm

Jun 07, 2026
pulisher
Jun 06, 2026

Dexcom G7 gave Type 2 adults 5 extra hours a day in range - Stock Titan

Jun 06, 2026
pulisher
Jun 06, 2026

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin - The AI Journal

Jun 06, 2026
pulisher
Jun 06, 2026

Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study - Reuters

Jun 06, 2026
pulisher
Jun 06, 2026

DexCom, Inc. Announces Results From CONNECT Randomized Controlled Trial Demonstrating Use Of Dexcom G7 Leads To Clinically And Statistically Significant Reduction In A1C And Improvement In Glucose Control Among People With Type 2 Diabetes N - marketscreener.com

Jun 06, 2026
pulisher
Jun 06, 2026

Assessing DexCom (DXCM) Valuation After Recent Share Price Momentum - Yahoo Finance

Jun 06, 2026
pulisher
Jun 05, 2026

Dexcom (DXCM) EVP Jon Coleman sells 9,823 shares in planned trades - Stock Titan

Jun 05, 2026
pulisher
Jun 05, 2026

Dexcom buys Nutrisense; Insulet rolls out patch pump update - MedTech Dive

Jun 05, 2026
pulisher
Jun 05, 2026

Stifel Adjusts Price Target on DexCom to $90 From $85, Maintains Buy Rating - marketscreener.com

Jun 05, 2026
pulisher
Jun 05, 2026

Is DexCom Stock Underperforming the Dow? - Yahoo Finance

Jun 05, 2026
pulisher
Jun 05, 2026

DXCM News | DEXCOM INC (NASDAQ:DXCM) - ChartMill

Jun 05, 2026
pulisher
Jun 04, 2026

DXCM (NASDAQ: DXCM) affiliate files Form 144; director sold 4,912 shares - Stock Titan

Jun 04, 2026
pulisher
Jun 04, 2026

Here's Why You Should Retain DexCom Stock in Your Portfolio - The Globe and Mail

Jun 04, 2026
pulisher
Jun 04, 2026

[Latest] Non-Invasive Blood Glucose Monitoring Devices Market Size to Hit USD 340.49 Million with a Promising CAGR of 25.60% by 2034 - GlobeNewswire Inc.

Jun 04, 2026
pulisher
Jun 04, 2026

DexCom (DXCM) Showcases Innovations and Future Plans at ADA Scie - GuruFocus

Jun 04, 2026
pulisher
Jun 04, 2026

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026 - StreetInsider

Jun 04, 2026
pulisher
Jun 04, 2026

DexCom vs. Insulet: Growth Trajectories and Valuations for InvestorsNews and Statistics - IndexBox

Jun 04, 2026
pulisher
Jun 04, 2026

DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026? - Yahoo Finance

Jun 04, 2026
pulisher
Jun 04, 2026

Dexcom Reaffirms CGM Benefits for All People With Diabetes and C - GuruFocus

Jun 04, 2026
pulisher
Jun 04, 2026

Dexcom to present diabetes study, launch new app, acquire Nutrisense By Investing.com - Investing.com Nigeria

Jun 04, 2026
pulisher
Jun 04, 2026

Dexcom to present diabetes study, launch new app, acquire Nutrisense - Investing.com

Jun 04, 2026
pulisher
Jun 04, 2026

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026 – Company AnnouncementFT.com - Financial Times

Jun 04, 2026
pulisher
Jun 03, 2026

Elliott strikes Dexcom board settlement after taking stake - MSN

Jun 03, 2026
pulisher
Jun 03, 2026

[144] DEXCOM INC SEC Filing - Stock Titan

Jun 03, 2026
pulisher
Jun 02, 2026

Did FDA-App Recalls and Activist Pressure Just Rewire Dexcom’s (DXCM) Software-Driven Investment Narrative? - Yahoo Finance

Jun 02, 2026
pulisher
Jun 02, 2026

Dexcom Inc. stock (US2521311074): customer advisory report and recent trading in focus - AD HOC NEWS

Jun 02, 2026
pulisher
Jun 02, 2026

DexCom Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jun 02, 2026
pulisher
Jun 02, 2026

The FDA Has Issued a Warning on 2 Popular Glucose Monitors. You Won't Believe Why. - Men's Health

Jun 02, 2026

Finanzdaten der Dexcom Inc-Aktie (DXCM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Dexcom Inc-Aktie (DXCM) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Coleman Jon
EVP, Chief Commercial Officer
Jun 03 '26
Sale
73.00
4,912
358,576
100,361
$63.76
price down icon 3.41%
PHG PHG
$25.67
price down icon 3.13%
STE STE
$208.10
price down icon 2.25%
ZBH ZBH
$88.17
price down icon 1.63%
EW EW
$85.98
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):